The role of rare compound heterozygous events in autism spectrum disorder
- PMID: 32572023
- PMCID: PMC7308334
- DOI: 10.1038/s41398-020-00866-7
The role of rare compound heterozygous events in autism spectrum disorder
Abstract
The identification of genetic variants underlying autism spectrum disorders (ASDs) may contribute to a better understanding of their underlying biology. To examine the possible role of a specific type of compound heterozygosity in ASD, namely, the occurrence of a deletion together with a functional nucleotide variant on the remaining allele, we sequenced 550 genes in 149 individuals with ASD and their deletion-transmitting parents. This approach allowed us to identify additional sequence variants occurring in the remaining allele of the deletion. Our main goal was to compare the rate of sequence variants in remaining alleles of deleted regions between probands and the deletion-transmitting parents. We also examined the predicted functional effect of the identified variants using Combined Annotation-Dependent Depletion (CADD) scores. The single nucleotide variant-deletion co-occurrence was observed in 13.4% of probands, compared with 8.1% of parents. The cumulative burden of sequence variants (n = 68) in pooled proband sequences was higher than the burden in pooled sequences from the deletion-transmitting parents (n = 41, X2 = 6.69, p = 0.0097). After filtering for those variants predicted to be most deleterious, we observed 21 of such variants in probands versus 8 in their deletion-transmitting parents (X2 = 5.82, p = 0.016). Finally, cumulative CADD scores conferred by these variants were significantly higher in probands than in deletion-transmitting parents (burden test, β = 0.13; p = 1.0 × 10-5). Our findings suggest that the compound heterozygosity described in the current study may be one of several mechanisms explaining variable penetrance of CNVs with known pathogenicity for ASD.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.J Cell Mol Med. 2021 Mar;25(5):2459-2470. doi: 10.1111/jcmm.16161. Epub 2021 Jan 21. J Cell Mol Med. 2021. PMID: 33476483 Free PMC article.
-
An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray.Sci Rep. 2020 Feb 21;10(1):3198. doi: 10.1038/s41598-020-59922-3. Sci Rep. 2020. PMID: 32081867 Free PMC article.
-
Meta-Analyses Support Previous and Novel Autism Candidate Genes: Outcomes of an Unexplored Brazilian Cohort.Autism Res. 2020 Feb;13(2):199-206. doi: 10.1002/aur.2238. Epub 2019 Nov 6. Autism Res. 2020. PMID: 31696658
-
Copy number variants in autism spectrum disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:421-427. doi: 10.1016/j.pnpbp.2019.02.012. Epub 2019 Feb 20. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30797015 Review.
-
Genetic research in autism spectrum disorders.Curr Opin Pediatr. 2015 Dec;27(6):685-91. doi: 10.1097/MOP.0000000000000278. Curr Opin Pediatr. 2015. PMID: 26371945 Free PMC article. Review.
Cited by
-
An integrative scoring approach for prioritization of rare autism spectrum disorder candidate variants from whole exome sequencing data.Sci Rep. 2025 Apr 15;15(1):13024. doi: 10.1038/s41598-025-96063-x. Sci Rep. 2025. PMID: 40234546 Free PMC article.
-
Comparison of three bioinformatics tools in the detection of ASD candidate variants from whole exome sequencing data.Sci Rep. 2023 Nov 1;13(1):18853. doi: 10.1038/s41598-023-46258-x. Sci Rep. 2023. PMID: 37914828 Free PMC article.
-
Autism Spectrum Disorder: Genetic Mechanisms and Inheritance Patterns.Genes (Basel). 2025 Apr 23;16(5):478. doi: 10.3390/genes16050478. Genes (Basel). 2025. PMID: 40428300 Free PMC article. Review.